Janney Montgomery Scott LLC Rani Therapeutics Holdings, Inc. Call Options Transaction History
Janney Montgomery Scott LLC
- $35.3 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$495,8000.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$306,0220.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$278,0650.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$187,7000.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$121,6540.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $15.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...